TKTakashi Kanbayashi

Takashi Kanbayashi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Takashi Kanbayashi has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Haruko Tsukamoto

    Department of Pediatrics, Nagoya City University Medical School, Nagoya, Japan

    1 shared publication
  • Rika Aizawa

    Department of Neuropsychiatry, Akita University School of Medicine, Akita, Japan

    1 shared publication
  • Seiji Nishino

    Center for Narcolepsy, Stanford University School of Medicine, CA, USA

    1 shared publication
  • Shigeru Chiba

    Department of Neuropsychiatry, Asahikawa Medical College, Asahikawa, Japan

    1 shared publication
  • Tetsuo Shimizu

    Department of Neuropsychiatry, Akita University School of Medicine, Akita, Japan

    1 shared publication
  • Yasushi Saito

    Department of Neuropsychiatry, Akita University School of Medicine, Akita, Japan

    1 shared publication

Latest Publications

  • Open Access

    CSF hypocretin‐1 (orexin‐A) concentrations in narcolepsy with and without cataplexy and idiopathic hypersomnia

    by Takashi Kanbayashi, Yuichi Inoue, Shigeru Chiba, Rika Aizawa, Yasushi Saito, Haruko Tsukamoto, Yukiharu Fujii, Seiji Nishino, Tetsuo Shimizu

    We measured cerebrospinal fluid (CSF) hypocretin‐1 levels in 11 patients with narcolepsy–cataplexy, five with narcolepsy without cataplexy and 12 with idiopathic hypersomnia (IHS). All patients were Japanese. As reported in Caucasian patients, undetectable or very low hypocretin‐1 levels were observed in most (9 out of 11) Japanese narcolepsy–cataplexy patients. Our hypocretin‐deficient narcoleptics included three prepubertal cases within few months after the disease onset. All nine hypocretin‐deficient patients were human leuckocyte antigen (HLA) DR2 positive, while two who had normal CSF hypocretin‐1 levels were HLA DR2 negative. In contrast, none of the narcolepsy without cataplexy and IHS subjects had undetectable low levels. Low CSF hypocretin‐1 is therefore very specific for HLA DR2 positive narcolepsy–cataplexy, and the deficiency is likely to be established at the early stage of the disease.